Services

Listings
  • Anti-FGFR2 (clone 12931)-sulfo-SMCC-DM1 ADC

    Anti-FGFR2 (clone 12931)-sulfo-SMCC-DM1 ADC

    Drug Development Shirley (New York) December 15, 2017 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-fgfr2-43.htm This ADC product is comprised of an anti-FGFR2 monoclonal antibody (clone 12931) conjugated via a sulfo-SMCC linker to DM1. The DM1 is targeted to certain cancers by immunerecognition and deliv...

  • Anti-FGFR2 (clone 12947)-sulfo-SMCC-DM1 ADC

    Anti-FGFR2 (clone 12947)-sulfo-SMCC-DM1 ADC

    Drug Development Shirley (New York) December 15, 2017 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-fgfr2-43.htm This ADC product is comprised of an anti-FGFR2 monoclonal antibody (clone 12947) conjugated via a sulfo-SMCC linker to DM1. The DM1 is targeted to certain cancers by immunerecognition and deliv...

  • Anti-FGFR2 (clone 12422)-sulfo-SMCC-DM1 ADC

    Anti-FGFR2 (clone 12422)-sulfo-SMCC-DM1 ADC

    Drug Development Shirley (New York) December 15, 2017 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-fgfr2-43.htm This ADC product is comprised of an anti-FGFR2 monoclonal antibody (clone 12422) conjugated via a sulfo-SMCC linker to DM1. The DM1 is targeted to certain cancers by immunerecognition and deliv...

  • Anti-FGFR2 (clone 11722)-sulfo-SMCC-DM1 ADC

    Anti-FGFR2 (clone 11722)-sulfo-SMCC-DM1 ADC

    Drug Development Shirley (New York) December 15, 2017 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-fgfr2-43.htm This ADC product is comprised of an anti-FGFR2 monoclonal antibody (clone 11722) conjugated via a sulfo-SMCC linker to DM1. The DM1 is targeted to certain cancers by immunerecognition and deliv...

  • Anti-FGFR2 (clone 10923)-sulfo-SMCC-DM1 ADC

    Anti-FGFR2 (clone 10923)-sulfo-SMCC-DM1 ADC

    Drug Development Shirley (New York) December 15, 2017 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-fgfr2-43.htm This ADC product is comprised of an anti-FGFR2 monoclonal antibody (clone 10923) conjugated via a sulfo-SMCC linker to DM1. The DM1 is targeted to certain cancers by immunerecognition and deliv...

  • Anti-FGFR2 (clone 10918)-sulfo-SMCC-DM1 ADC

    Anti-FGFR2 (clone 10918)-sulfo-SMCC-DM1 ADC

    Drug Development Shirley (New York) December 15, 2017 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-fgfr2-43.htm This ADC product is comprised of an anti-FGFR2 monoclonal antibody (clone 10918) conjugated via a sulfo-SMCC linker to DM1. The DM1 is targeted to certain cancers by immunerecognition and deliv...

  • How Ensuring Data Integrity in Method Validations

    How Ensuring Data Integrity in Method Validations

    Data Management Fremont (California) December 8, 2017 Free

    Overview: The webinar will also illustrate the lifecycle management of analytical procedures and train attendees on documentation requirements to ensure Data Integrity. Why should you Attend: The guidance changes how FDA regulated methods will be dev...

  • NDAs and INDs for Orally-Administered Drug Products

    NDAs and INDs for Orally-Administered Drug Products

    Training and Teaching Fremont (California) December 8, 2017 Free

    Overview: This webinar will be helpful to applicants conducting BA/BE studies during the IND period, also FDA guidance recommendations on how to meet the BA and BE requirements in 21 CFR 320 as they apply to oral dosage forms. Why should you Attend: ...

  • Final Rules of Unique Device Identification

    Final Rules of Unique Device Identification

    Training and Teaching Fremont (California) December 8, 2017 Free

    Overview: This webinar will address the four key steps to compliance by device manufacturers. Also covered will be the Final Rule's provisions to address existing FG inventory, not properly labeled. Why should you Attend: It will also review the impl...

  • How to plan risk based approaches for clinical trials

    How to plan risk based approaches for clinical trials

    Clinical Fremont (California) December 8, 2017 Free

    Overview: You will understand how to identify, evaluate and also how to implement specific risk based techniques for risk management used in clinical trials. Areas Covered in the Session: Have explained key risk based process/tools and techniques Rev...

  • Practices for Active Pharmaceutical Ingredients per ICH Q7

    Practices for Active Pharmaceutical Ingredients per ICH Q7

    Clinical Fremont (California) December 8, 2017 Free

    Overview: The APIs covered in this guidance document include new chemical entities and APIs of biological origin and those created by biotech processes. Why should you Attend: This document was created to fulfil the need for specific guidance with re...

  • How to Accurate Adverse Event Reporting

    How to Accurate Adverse Event Reporting

    Training and Teaching Fremont (California) December 8, 2017 Free

    Overview: Learn why the single most important function of the Principal Investigator and the study conduct team is the awareness, assessment, and management of Adverse Events occurring during the conduct of clinical research with drugs or devices uti...